Herbs, menopause, and dialysis

Seminars in Dialysis

Volumn 15, Issue 1, 2002, Pages 53-59

  Roemheld Hamm, Beatrix ^a   Dahl, Naomi V ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT MEDICINAL PRODUCT;

CASE REPORT; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; RENAL REPLACEMENT THERAPY; REVIEW;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; RENAL DIALYSIS;

EID: 0036372056     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139x.2002.00018.x     Document Type: Review

References (100)

1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280:1569-1575, 1998
2. Holley JL, Schmidt RJ: Hormone replacement therapy in postmenopausal women with end-stage renal disease: a review of the issues. Semin Dial 14: 146-149, 2001
3. Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M: Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 29:685-690, 1997
4. Stehman-Breen CO, Gillen D, Gipson D: Prescription of hormone replacement therapy in postmenopausal women with renal failure. Kidney Int 56:2243-2247, 1999
5. American College of Obstetricians and Gynecologists: Use of botanicals for management of menopausal symptoms. Clinical practice guidelines for obstetrician-gynecologists. Available at http://www.acog.org/from_home/ publications/misc/pb028.htm, accessed September 1, 2001
6. Foote J, Cohen B: Medicinal herb use and the renal patient. J Ren Nutr 8: 40-42, 1998
7. Dahl NV: Herbs and supplements in dialysis patients: panacea or poison? Semin Dial 14:186-192, 2001
8. Geraghty ME: Herbal supplements for renal patients: what do we know? Nephrol News Issues 14:12-13, 2000
9. Tyler VE: Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994
10. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines, 1st ed. Boston, MA: American Botanical Council, 1998
11. Liske E: Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv Ther 15:45-53, 1998
12. Foster S: Black cohosh (Cimicifuga racemosa): a literature review. Herbalgram 45:35-49, 1999
13. Blumenthal M, Goldberg A, Brinckmann J (eds). Herbal Medicine Expanded Commission E Monographs. Newton, MA: Integrative Medicine Communications, 2000
14. Lieberman S: A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Womens Health 7:525-529, 1998
15. Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, Lo KM, Moore A, Rosenman PJ, Kaufman EL, Neugut AI, Grann VR: Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19:2739-2745, 2001
16. Lehmann-Willenbrock E, Riedel HH: Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zentralbl Gynakol 110:611-618, 1988
17. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K: Cimicifuga and elbrosia lack oestrogenic effects in mice and rats. Maturitas 25:149-153, 1996
18. Kruse SO, Lohning A, Pauli GF, Winterhoff H, Nahrstedt A: Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Med 65:763-764, 1999
19. Gruenwald J: Standardized black cohosh (Cimicifuga) extract clinical monograph. Q Rev Nat Med 3:117-125, 1998
20. Pepping J: Black cohosh: Cimicifuga racemosa. Am J Health Syst Pharm 56:1400-1402, 1999
21. Jellin JM, Gregory P, Batz F, Hitchens K, Burson S, Shaver K, Palacioz K: Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database, 3rd ed. Stockton, CA: Therapeutic Research Faculty, 2000
22. Newall CA, Anderson LA, Philpson JD: Herbal Medicine: A Guide for Healthcare Professionals. London: Pharmaceutical Press, 1996
23. Schulz V, Hansel R, Tyler VE: Rational Phytotherapy: A Physician's Guide to Herbal Medicine, 3rd ed. Berlin: Springer, 1998
24. Product review: Asian and American ginseng. ConsumerLab.com. Available at http://www.consumerlab.com/results/ginseng.asp, accessed September 9, 2001
25. Gurley BJ, Gardner SF, Hubbard MA: Clinical assessment of potential cytochrome P450-mediated herb-drug interactions (poster presentation). AAPS annual meeting and exposition, Indianapolis, IN, 2000
26. Schellenberg R: Treatment for the premenstrual syndrome with agnus-castus fruit extract: prospective, randomised, placebo controlled study. BMJ 322:134-137, 2001
27. Mills S, Bone K: Principles and Practice of Phytotherapy. London: Churchill Livingstone, 2000
28. The Renew of Natural Products. St. Louis: Facts and Comparisons, 2000
29. Brown D: Vitex agnus-castus clinical monograph. Q Rev Nat Med 2:111-121, 1994
30. Merz PG, Gorkow C, Schrodter A, Rietbrock S, Sieder C, Loew D, Dericks-Tan JS, Taubert HD: The effects of a special agnus-castus extract (BP1095E1) on prolactin secretion in healthy male subjects. Exp Clin Endocrinol Diabetes 104:447-453, 1996
31. McCaleb RS, Leigh E, Morien K: The Encyclopedia of Popular Herbs. Roseville, CA: Prima Health, 2000
32. McGuffin M (ed): American Herbal Products Association's Botanocal Safety Handbook. Boca Raton, FL: CRC Press, 1997
33. Jarry H, Leonhardt S, Gorkow C, Wuttke W: In vitro prolactin but not LH and FSH release inhibited by compounds in extracts of agnus-castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol Diabetes 102:448-454, 1994
34. Wuttke W: Dopaminergic action of extracts of agnus-castus. Forschen Komplementarmedizen 3:329-330, 1996
35. Bratman S, Kroll D: Natural Health Bible. Rocklin, CA: Prima Publishing, 1999
36. Foster S, Tyler VE: Tyler's Honest Herbal, 4th ed. Binghamton, NY: Haworth Herbal Press, 1999
37. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B: Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 68:981-956, 1997
38. Brinker F: Herb Contraindications and Drug Interactions, 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998
39. Heck AM, DeWitt BA, Lukes AL: Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 57:1221-1227, 2000
40. Page RL, Lawrence JD: Potentiation of warfarin by dong quai. Pharmacotherapy 19:870-876, 1999
41. Noris M, Remuzzi G: Uremic bleeding: closing the circle after 30 years of controversies? Blood 94:2569-2574, 1999
42. Belch J, Hill A: Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr 71:S352-S356, 2000
43. Hardy ML: Herbs of special interest to women. J Am Pharm Assoc 40: 234-242, 2000
44. Pye JK, Mansel RE, Hughes LE: Clinical experience of drug treatments for mastalgia. Lancet 2:373-377, 1985
45. Khoo SK, Munro C, Battistutta D: Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 153:189-192, 1990
46. Budeiri D, Li Wan Po A, Dornan JC: Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 17:60-68, 1996
47. Chenoy R, Hussain S, Tayob Y, O'Brien PM, Moss MY, Morse PF: Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308:501-503, 1994
48. Leung AY, Foster S: Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 2nd ed. New York: John Wiley & Sons, 1996
49. Guivernau M, Meza N, Barja P, Roman O: Clinical and experimental study on the long-term effect of dietary gamma-linoleic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids 51:311-316, 1994
50. Fueh-Berman A: Estriol: a kinder, gentler estrogen? Altern Ther Womens Health 1:51-52, 1999
51. van Haaften M, Donker GH, Sie-Go DM, Haspels AA, Thijssen JH: Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women. Gynecol Endocrinol 11:175-185, 1997
52. Granberg S, Ylostalo P, Wikland M, Karlsson B: Endometrial sonographic and histologic findings in women with and without hormonal replacement therapy suffering from postmenopausal bleeding. Maturitas 27:35-40, 1997
53. Tzingounis VA, Aksu MF, Greenblatt RB: Estriol in the management of the menopause. JAMA 239:1638-1641, 1978
54. Langer RD: Micronized progesterone: a new therapeutic option. Int J Fertil Womens Med 44:67-73, 1999
55. Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E: Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 92:982-988, 1998
56. Leonetti HB, Longo S, Anasti JN: Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 94:225-228, 1999
57. Burry KA, Paton PE, Hermsmeyer K: Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. Am J Obstet Gynecol 180:1504-1511, 1999
58. Cooper A, Spencer C, Whitehead MI, Ross D, Barnard GJ, Collins WP: Systemic absorption of progesterone from Progest cream in postmenopausal women. Lancet 351:1255-1256, 1998
59. Katz S, Morales AJ: Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DS) as therapeutic options in menopause. Semin Reprod Endocrinol 16:161-170, 1998
60. Bamhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE: The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84: 3896-3902, 1999
61. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL: A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85:2832-2838, 2000
62. Pepping J: DHEA: dehydroepiandrosterone. Am J Health Syst Pharm 57:2044-2048 2056, 2000
63. Parasrampuria J, Schwartz K, Petesch R: Quality control of dehydroepiandrosterone dietary supplement products. JAMA 280:1565, 1998
64. Skolnick AA: Scientific verdict still out on DHEA. JAMA 276:1365-1367, 1996
65. Eagon PK, Elm MS, Hunter DS, Bergerson J, Ayers HH, Tress NB, Eagon CL: Medicinal herbs: modulation of estrogen action. Conference proceedings: Era of Hope Meeting for the Department of Defense Breast Cancer Research Program, Atlanta, GA, 2000
66. Lindberg JS, Moe SM: Osteoporosis in end-state renal disease. Semin Dial 19:115-122, 1999
67. Mattix H, Singh AK: Estrogen replacement therapy: implications for postmenopausal women with end-stage renal disease. Current Opinions in Nephrology and Hypertension 9:201-214, 2000
68. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenek-Gustafsson K, Smith SC Jr, Taubert KA, Wenger NK: Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 104:499-503, 2001
69. Kurzer MS, Xu X: Dietary phytoestrogens. Annu Rev Nutr 17:353-381, 1997
70. Strauss L, Santti R, Saarinen N, Streng T, Joshi S, Makela S: Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol Lett 102-103:349-354, 1998
71. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D: The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 91:6-11, 1998
72. Brzezinski A, Adlercreutz H, Sheoul R, Rosler A, Shmueli A, Tanos V, Schenker JK: Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 4:89-94, 1997
73. Kurzer M: Hormonal effects of soy isoflavones: studies in premenopausal and postmenopausal women. J Nutr 130:S660-S661, 2000
74. Tham DM, Gardner CD, Haskell WL: Clinical review 97: potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83:2223-2235, 1998
75. Washburn S, Burke GL, Morgan T, Anthony M: Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6:7-13, 1999
76. Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68:S1333-S1346, 1998
77. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr: Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68:1375S-1379S, 1998
78. Crouse JR III, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159:2070-2076, 1999
79. Sirtori CR, Pazzucconi F, Colombo L, Battistin P, Bondioli A, Descheemaeker K: Double-blind study of the addition of high-protein soy milk v. cows' milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins. Br J Nutr 82:91-96, 1999
80. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW Jr, Hasler CM: Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 71:1077-1084, 2000
81. Wong WW, Smith EO, Stuff JE, Hachey DL, Heird WC, Pownell HJ: Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr 68:S1385-S1389, 1998
82. Nilausen K, Meinertz H: Variable lipemic response to dietary soy protein in healthy, normolipemic men. Am J Clin Nutr 68:S1380-S1384, 1998
83. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282, 1995
84. Simons LA, von Konigsmark M, Simons J, Celermajer DS: Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 85:1297-1301, 2000
85. Lissin LW, Cooke JP: Phytoestrogens and cardiovascular health. J Am Coll Cardiol 35:1403-1410, 2000
86. Setchell KD, Cassidy A: Dietary isoflavones: biological effects and relevance to human health. J Nutr 129:S758-S767, 1999
87. Soroka N, Silverberg DS, Greemland M, Birk Y, Blum M, Peer G, Iaina A: Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron 79:173-180, 1998
88. Gentile MG, Fellin G, Cofano F, Delle FA, Manna G, Ciceri R, Petrini C, Lavarda F, Pozzi F, D'Amico G: Treatment of proteinuric patients with a vegetarian soy diet and fish oil. Clin Nephrol 40:315-320, 1993
89. D'Amico G, Gentile MG: Effect of dietary manipulation on the lipid abnormalities and urinary protein loss in nephrotic patients. Miner Electrolyte Metab 18:203-206, 1992
90. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T: Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852, 2000
91. Fanti O: Systematic administration of genistein partially prevents bone loss in ovariectomized rates in a nonestroeen-like mechanism. Am J Clin Nutr 68(suppl):1517, 1998
92. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC: Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167, 1996
93. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC: Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 68:S1364-S1368, 1998
94. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC: Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 68:S1358-S1363, 1998
95. Lees O, Ginn TA: Soy protein isolate diet does not prevent increased cortical bone turnover in ovariectomized macaques. Calcif Tissue Int 62:557-558, 1998
96. Barnes S: Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab 12:559-579, 1998
97. Fanti P, Sawaya BP, Custer LJ, Franke AA: Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients. J Am Soc Nephrol 10:864-871, 1999
98. Heaney RP, Dowell MS, Rafferty K, Bierman J: Bioavailability of the calcium in fortified soy imitation milk, with some observations on method. Am J Clin Nutr 71:1166-1169, 2000
99. USDA Nutrient Database for Standard Reference, release July 14, 2001. Soybeans. NDB nos. 11451 and 16111. Available at http://www.nal.usda.gov/fnic/ cgi-bin/nut_search.pl, accessed September 9, 2001
100. Bakhit RM, Klein BP, Essex-Sorlie D, Ham JO, Erdman JW Jr, Potter SM: Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. J Nutr 124:213-222, 1994